泰地罗新注射液体外抑菌试验及对感染副猪嗜血杆菌仔猪的保护作用

李国基,闫超群,麻雨桥,谢顺,顾欣,曹莹,黄士新,黄显会

Antibacterial Activity in Vitro and Protection of Tildipirosin Injection Against Artificially Infected Haemophilus Paracoides in Piglets

GuoJi LI,ChaoQun YAN,YuQiao MA,Shun XIE,Xin GU,Ying CAO,ShiXin HUANG,XianHui HUANG

表5 给药后各实验组平均体温及标准差

Table 5 Mean temperature and standard deviation of each experimental group after administration

时间 Time (h) 健康对照组 Healthy control group 泰地罗新注射液 高剂量组 High dose group of Tildipirosin injection 泰地罗新注射液 中剂量组 Middle dose group of Tildipirosin injection 泰地罗新注射液 低剂量组 Low dose group of Tildipirosin injection 泰拉霉素注射液 Tulathromycin injection 感染对照组 Infective control group 0 39.2±0.18 39.4±0.19 39.1±0.22 39.2±0.20 38.9±0.22 39.3±0.31 1 39.1±0.19 40.2±0.18 40.6±0.23 40.4±0.22 40.2±0.18 40.5±0.29 3 39.2±0.22 41.2±0.21 41±0.19 41.1±0.21 41.2±0.21 41±0.22 4 38.6±0.21 40.9±0.20 40.8±0.17 41.3±0.22 41.1±0.19 41.8±0.28 6 39.3±0.20 40.4±0.19 40.4±0.16 40.7±0.24 40.7±0.23 41.2±0.17 8 39.1±0.17 40.1±0.23 40±0.21 40.5±0.18 40.3±0.21 40.8±0.19 12 38.9±0.20 39.5±0.18 39.5±0.22 40.2±0.19 39.6±0.18 40.9±0.24 24 39±0.19 39.3±0.23 39.5±0.18 40.2±0.22 39.2±0.19 40.6±0.22 36 39.2±0.23 39.4±0.25 39.1±0.19 39.5±0.22 39.4±0.27 40.5±0.28 48 38.8±0.16 39.2±0.21 39.3±0.20 39.5±0.24 39.1±0.26 40.7±0.26 60 39.1±0.21 39.2±0.20 39±0.20 39.4±0.22 38.9±0.29 40.8±0.21 72 38.9±0.22 38.9±0.17 39.4±0.22 39.3±0.22 39.2±0.19 40.6±0.27 84 39.2±0.18 39.3±0.22 39.4±0.25 38.9±0.21 39±0.18 40.5±0.30 96 39.1±0.19 38.8±0.20 38.9±0.21 39.2±0.22 39.3±0.21 40.4±0.22 108 39.3±0.20 39.1±0.24 39.2±0.19 39.1±0.19 38.9±0.21 40.5±0.22 120 38.7±0.22 39.1±0.22 39±0.17 39.4±0.22 39.2±0.22 40.4±0.24 132 39.2±0.18 39.2±0.19 39.2±0.20 38.8±0.24 39.4±0.19 40.3±0.25 144 39.1±0.21 39.2±0.21 39.3±0.20 39.2±0.21 39.1±0.21 40.4±0.21 156 39.4±0.21 39.4±0.25 39.2±0.18 39±0.22 39.2±0.18 40.3±0.24